Adam Tomasi
President at ALLAKOS INC.
Net worth: 779 011 $ as of 2024-03-30
Profile
Dr. Adam L. Tomasi is a President & Chief Operating Officer at Allakos, Inc. He is on the Board of Directors at Attune Pharmaceuticals, Inc. Dr. Tomasi was previously employed as a Chief Scientific Officer by ZS Pharma, Inc., a Principal by Alta Partners Management Corp., a Medicinal Chemist by Cytokinetics, Inc., and a Medicinal Chemist by Gilead Sciences, Inc. He received his undergraduate degree from the University of California, Berkeley, an MBA from MIT Sloan School of Management and a doctorate degree from the University of California, Irvine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALLAKOS, INC.
0.70% | 2024-03-04 | 618,263 ( 0.70% ) | 779 011 $ | 2024-03-30 |
Adam Tomasi active positions
| Companies | Position | Start |
|---|---|---|
| ALLAKOS INC. | President | 2019-07-31 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Director/Board Member | - |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Director/Board Member | - |
Former positions of Adam Tomasi
| Companies | Position | End |
|---|---|---|
| ZS PHARMA INC | Chief Tech/Sci/R&D Officer | 2017-02-28 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Private Equity Investor | - |
Training of Adam Tomasi
| University of California, Berkeley | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| ALLAKOS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
- Stock Market
- Insiders
- Adam Tomasi
